Targeted immunotherapy could boost radiotherapy response 08 Mar 2021 Profiling the ‘immune landscape’ of patient’s tumours reveals who will most benefit from radiotherapy with potential immunotherapy in bowel cancer. Tumours which are chronically Inflamed before treatment could be made more susceptible using targeted immunotherapies Find out more Show/Hide